Company Overview
Reliance Global Group, Inc. operates within the Financial Services sector as an insurance broker, focusing on the acquisition and management of wholesale and retail insurance agencies across the United States. The company provides comprehensive agency services covering insurance products in healthcare and medicare, personal and commercial lines, trucking, property and casualty, and general insurance brokerage. The firm currently employs 64 individuals to support its operations while maintaining a total market capitalization of $4.09 million and reporting trailing twelve-month revenue of $13.12 million. These valuation metrics, specifically a market cap significantly lower than the reported revenue, indicate a company operating on a micro-cap scale with limited market penetration relative to its financial output.
Financial Health
The company reported trailing twelve-month revenue of $13.12 million, yet this generated a net income of -$7,002,578 and an EBITDA of -$7,316,871, revealing a cost structure where expenses drastically exceed gross revenues. Despite the negative net income, the entity recorded positive free cash flow of $2.09 million, which suggests a degree of financial flexibility in managing cash outflows against inflows, though this does not offset the accounting losses. Margin analysis shows a gross margin of -14.5%, an operating margin of -156.8%, and a profit margin of -53.4%, indicating that the company is unable to cover its operating expenses or cost of goods sold with its current revenue streams. On the balance sheet, the company holds $2.58 million in cash against total debt of $7.06 million, resulting in a debt-to-equity ratio of 104.67% which characterizes the capital structure as highly leveraged. Liquidity is assessed via a current ratio of 1.47, suggesting that current assets are sufficient to cover short-term liabilities, though the margin between these figures is not substantial. Return on equity stands at -146.4% and return on assets is -32.9%, metrics that reveal management is currently ineffective at generating returns from the shareholder equity or the total asset base employed.
Valuation Assessment
The stock exhibits a trailing P/E ratio of 3.77 and a forward P/E of 0.85, implying that the market anticipates a significant reduction in losses or a rapid turnaround in earnings performance over the coming year. The price-to-book ratio is 0.58, indicating that the market values the company at less than half of its book value, which often reflects a lack of market premium or potential concerns regarding asset quality. Alternative valuation metrics such as the price-to-sales ratio of 0.31 and an EV/EBITDA of -0.98 suggest that the company is valued based on revenue multiples rather than earnings power due to its negative profitability. The stock has traded between a 52-week high of $3.55 and a 52-week low of $0.15, placing the current valuation in a range that requires precise calculation against the latest trading price to determine relative positioning. The beta value is 0.07, which indicates that the stock price exhibits extremely low volatility relative to the broader market, moving independently of general market fluctuations.
Growth & Income
Revenue growth year-over-year is -27.5%, while earnings growth is N/A due to the lack of positive earnings history, creating a scenario where the company is contracting in top-line revenue without a clear earnings trajectory to follow. The company does not pay dividends, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, meaning all available cash flow is retained or used for operational purposes rather than distributed to shareholders. Because the firm does not pay a dividend, the company reinvests its limited free cash flow into growth initiatives or debt reduction rather than providing income to investors. The overall growth and income profile is characterized by negative revenue expansion, zero dividend income, and a highly leveraged balance sheet that constrains future growth potential.